Brief Interventions for Drop-Out re-Engagement
We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome...
Brief Summary
Official Title: “Adaptive Brief Interventions for Drop-Out re-Engagement”
We will evaluate a series of interventions intended to help individuals who drop out of substance abuse treatment re-engage in order to improve treatment outcome.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind
Detailed Clinical Trial Description
We propose a 5-year Stage I behavioral therapy development study to: 1) prospectively evaluate risk factors for premature drop-out from outpatient treatment; 2) develop and test a manual of single session phone-and office-based interventions to re-engage these individual in treatment.
Intervention(s) in this Clinical Trial
- Behavioral: brief (behavioral therapy)
Outcome Measures for this Clinical Trial
Primary Measures
- retention into outpatient treatment
Secondary Measures
- substance abuse
- psychiatric symptons
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- admission to outpatient treatment
Exclusion Criteria:
- need for hospitalization
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 65 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: National Institute on Drug Abuse (NIDA) NIH
Overall Clinical Trial Officials and Contacts
Sam Ball, PhD Principal Investigator Yale School of Medicine
Overall Contact: Rebekka Palmer, PhD 203-781-2777 rebekka.palmer@yale.edu
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00350571
Study ID Number: 101010101
ClinicalTrials.gov Identifier: NCT00350571
Health Authority: United States: Federal Government
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00350571
